To Stop Osteoarthritis, Fixing Cartilage May Not Be Enough
2007; American College of Physicians; Volume: 147; Issue: 6 Linguagem: Inglês
10.7326/0003-4819-147-6-200709180-00024
ISSN1539-3704
Autores Tópico(s)Total Knee Arthroplasty Outcomes
ResumoCurrent Clinical Issues18 September 2007To Stop Osteoarthritis, Fixing Cartilage May Not Be EnoughJennifer Fisher WilsonJennifer Fisher WilsonSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-147-6-200709180-00024 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Fifty years ago, doctors knew little about osteoarthritis except that it damaged the joints and sometimes caused excessive pain. Today, the disease is far better understood—researchers have gained insight into the mechanical, genetic, and biochemical factors underlying osteoarthritis, and many pharmaceutical companies have long-standing programs devoted to the search for ways to prevent or slow the disease. However—notwithstanding the advent of surgery—most people with osteoarthritis today are little better off than those who had it 50 years ago.There is still no way to stop the progress of osteoarthritis once it starts corrupting joints. Treatment is symptomatic, focusing on strategies ...References1. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780-5. [PMID: 17403800] CrossrefMedlineGoogle Scholar2. Felson DT, Kim YJ. The futility of current approaches to chondroprotection. Arthritis Rheum. 2007;56:1378-83. [PMID: 17469094] CrossrefMedlineGoogle Scholar3. Spector TD, Conaghan PG, Buckland-Wright JC, Garnero P, Cline GA, Beary JF, et al. Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]. Arthritis Res Ther. 2005;7:R625-33. [PMID: 15899049] CrossrefMedlineGoogle Scholar4. Bingham CO, Buckland-Wright JC, Garnero P, Cohen SB, Dougados M, Adami S, et al. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum. 2006;54:3494-507. [PMID: 17075851] MedlineGoogle Scholar5. Brandt KD, Mazzuca SA, Katz BP, Lane KA, Buckwalter KA, Yocum DE, et al. Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial. Arthritis Rheum. 2005;52:2015-25. [PMID: 15986343] CrossrefMedlineGoogle Scholar6. Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354:795-808. [PMID: 16495392] CrossrefMedlineGoogle Scholar7. Reichenbach S, Sterchi R, Scherer M, Trelle S, Bürgi E, Bürgi U, et al. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med. 2007;146:580-90. [PMID: 17438317] LinkGoogle Scholar8. Brandt KD. Putting some muscle into osteoarthritis [Editorial]. Ann Intern Med. 1997;127:154-6. [PMID: 9230007] LinkGoogle Scholar9. Dieppe P, Brandt KD. What is important in treating osteoarthritis? Whom should we treat and how should we treat them? Rheum Dis Clin North Am. 2003;29:687-716. [PMID: 14603578] CrossrefMedlineGoogle Scholar10. Bukulmez H, Matthews AL, Sullivan CM, Chen C, Kraay MJ, Elston RC, et al. Hip joint replacement surgery for idiopathic osteoarthritis aggregates in families. Arthritis Res Ther. 2006;8:R25. [PMID: 16507126] CrossrefMedlineGoogle Scholar11. Loughlin J, Ferreira A, Dowling B, Southam L, Mustafa Z, Forster T, et al. Genetics of osteoarthritis. Arthritis Res Ther. 2004;6 Suppl 3 2. CrossrefGoogle Scholar12. Stein CM, Griffin MR, Taylor JA, Pichert JW, Brandt KD, Ray WA. Educational program for nursing home physicians and staff to reduce use of non-steroidal anti-inflammatory drugs among nursing home residents: a randomized, controlled trial. Med Care. 2001;39:436-45. [PMID: 11317092] CrossrefMedlineGoogle Scholar13. Ray WA, Stein CM, Byrd V, Shorr R, Pichert JW, Gideon P, et al. Educational program for physicians to reduce use of non-steroidal anti-inflammatory drugs among community-dwelling elderly persons: a randomized, controlled trial. Med Care. 2001;39:425-35. [PMID: 11317091] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: Disclosures: None disclosed.E-mail:[email protected]org. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byParacrine Effect of Synovial-Derived Stem Cells on Induced Knee Osteoarthritis in RatsIntra‐Articular Injection of Mesenchymal Stem Cells for the Treatment of Osteoarthritis of the Knee: A Proof‐of‐Concept Clinical TrialKnee Osteoarthritis Treatment with the KineSpring Knee Implant System: A Report of Two CasesThe KineSpring load absorber implant: rationale, design and biomechanical characterization 18 September 2007Volume 147, Issue 6Page: 437-439KeywordsBoneCartilageDrugsForecastingGenetic diseasesKneesMusclesOsteoarthritisSurgeryTotal hip replacement ePublished: 18 September 2007 Issue Published: 18 September 2007 Copyright & PermissionsCopyright © 2007 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Referência(s)